SLC30A8 and type 2 diabetes mellitus: These observations suggest that reducing the activity of ZnT8 might be considered a future therapeutic approach to the treatment of T2D, although care must be taken, since massive impairment of Zn2+ uptake strongly inhibits insulin production and secretion [63].